Amnis Therapeutics
Or Akiva
About Amnis Therapeutics
ITGI Medical is a bio-medical engineering company specializing in research and development, design, manufacture and distribution of high quality heterologous tissue covered stents for Cardiovascular and Neurovascular interventions. Their focus is on current technologies and applications that improve the standard of care for patients around the world in the fields of interventional Cardiology and Interventional Neuro-Radiology for the application in Coronary and neurological aneurysms, treatment of Fistulas, Saphenous Vein Graft occlusion (SVG Disease) and vascular perforations. Studies conducted prove that ITGI’s propriety technology can address these clinical problems in a safe and effective manner.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.2M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2017)
- Website: amnis.life
- Phone: 972 7 2220 0333
Industries & Categories
Developer Platform, Manufacturing, Medical
Canonical: https://fsome.com/organization/amnis-therapeutics-209113 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.